LEO LUZNIK to Precursor Cell Lymphoblastic Leukemia-Lymphoma
This is a "connection" page, showing publications LEO LUZNIK has written about Precursor Cell Lymphoblastic Leukemia-Lymphoma.
Connection Strength
0.755
-
This CAR won't start: predicting nonresponse in ALL. Blood Adv. 2023 08 08; 7(15):4215-4217.
Score: 0.352
-
Single-agent GVHD prophylaxis with posttransplantation cyclophosphamide after myeloablative, HLA-matched BMT for AML, ALL, and MDS. Blood. 2014 Dec 11; 124(25):3817-27.
Score: 0.191
-
Allogeneic Blood or Marrow Transplantation with High-Dose Post-Transplantation Cyclophosphamide for Acute Lymphoblastic Leukemia in Patients Age =55 Years. Transplant Cell Ther. 2023 03; 29(3):182.e1-182.e8.
Score: 0.084
-
Allogeneic transplantation for Ph+ acute lymphoblastic leukemia with posttransplantation cyclophosphamide. Blood Adv. 2020 10 27; 4(20):5078-5088.
Score: 0.072
-
Immunomodulatory Drugs: Immune Checkpoint Agents in Acute Leukemia. Curr Drug Targets. 2017; 18(3):315-331.
Score: 0.056